TITLE:
      Infusion Laboratory: Protocol 2 (Lisuride) - 3
SUMMARY:
      The purpose of this study is to evaluate clinical safety issues pertaining to lisuride, to
      cocaine, and to its interaction in a chronic, crack dependent population, and to determine
      how pretreatment with lisuride modifies the subjective as well as physiological effects of
      cocaine.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        M/F ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the
        study and sign informed consent.

        Exclusion Criteria:

        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
        and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.
        Acute hepatitis. Other medical condtions that deem participation to be unsafe.
